 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Gilead's Truvada Is Approved by the FDAAugust 30, 2004 The Food and Drug Administration approved Gilead's Truvada, a one-tablet, once-a-day dosed co-formulation of Viread and Emtriva. This medication combines 200 mg of emtricitabine and 300 mg of tenofovir fumarate. This once-a-day new combination may make it easier for doctors when prescribing new regimens. Truvada must be taken in combination with other anti-HIV medications to achieve maximum viral suppression. The company is planning to sell Truvada to the developing world at a not-profit price through Gilead's Access Program. The developing world counts for more than 70% of all infections. For more information on Truvada, go to Gilead.com, talk to your doctor or call the STEP Program at 1-888-399-7837.  This article was provided by Seattle Treatment Education Project. It is a part of the publication STEP Ezine. |
 |
Email
Print-Friendly
Glossary
PDF
The Body: About The Body | Contact The Body | Site Policies | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
